Anzeige
Mehr »
Login
Donnerstag, 16.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0HMX9 | ISIN: GB00B0N8QD54 | Ticker-Symbol: B6S
Frankfurt
15.01.25
08:10 Uhr
14,900 Euro
-0,600
-3,87 %
1-Jahres-Chart
BRITVIC PLC Chart 1 Jahr
5-Tage-Chart
BRITVIC PLC 5-Tage-Chart
RealtimeGeldBriefZeit
15,40016,00023:00
Dow Jones News
233 Leser
Artikel bewerten:
(1)

Britvic plc: Scheme of Arrangement becomes effective

Finanznachrichten News

DJ Britvic plc: Scheme of Arrangement becomes effective

Britvic plc (BVIC ) 
Britvic plc: Scheme of Arrangement becomes effective 
16-Jan-2025 / 18:07 GMT/BST 
=---------------------------------------------------------------------------------------------------------------------- 
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY 
JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION 
FOR IMMEDIATE RELEASE 
16 January 2025 
 
RECOMMENDED CASH ACQUISITION 
of 
Britvic PLC ("Britvic") 
by 
Carlsberg UK Holdings Limited ("Carlsberg") 
(a wholly owned subsidiary of Carlsberg A/S) 
to be effected by means of a scheme of arrangement under 
 Part 26 of the Companies Act 2006 
SCHEME OF ARRANGEMENT BECOMES EFFECTIVE 
On 8 July 2024, the boards of Britvic and Carlsberg announced that they had reached agreement on the terms of a 
recommended cash offer to be made by Carlsberg to acquire the entire issued and to be issued ordinary share capital of 
Britvic (the "Acquisition") to be effected by means of a Court-sanctioned scheme of arrangement under Part 26 of the 
Companies Act 2006 (the "Scheme"). 
On 17 December 2024, Carlsberg and Britvic announced that all regulatory conditions set out in Part A of Part III ( 
Conditions to the implementation of the Scheme and to the Acquisition) of the Scheme Document had been satisfied. On 15 
January 2025, Britvic announced that the Court had issued the Court Order sanctioning the Scheme on that day. 
Scheme Effective 
Britvic and Carlsberg are pleased to announce that, following the delivery of a copy of the Court Order to the 
Registrar of Companies, the Scheme has today become Effective in accordance with its terms and the entire issued 
ordinary share capital of Britvic is now owned by Carlsberg. 
Suspension and cancellation of listing and trading of Britvic Shares 
Britvic Shareholders on the register of members at the Scheme Record Time, being 6.00 p.m. on 16 January 2025, will 
receive 1,315 pence for each Scheme Share in cash (the "Acquisition Value"). The Acquisition Value comprises for each 
Scheme Share: 
   -- 1,290 pence in cash in consideration for each Scheme Share; and 
   -- a special dividend payment of 25 pence per Scheme Share which will be paid by Britvic within 14 days of 
  today's date, being no later than 30 January 2025 (the "Special Dividend"). 
As previously announced on 15 January 2025, applications were made for the suspension, and subsequent cancellation, of 
the listing of Britvic Shares on the Official List and the admission of Britvic Shares to trading on the London Stock 
Exchange's main market for listed securities (the "Main Market"), and therefore the listing of Britvic Shares on the 
Official List and dealings in Britvic Shares on the Main Market shall be suspended at 7.30 a.m. (London time) on 17 
January 2025. 
The cancellation of the listing of Britvic Shares on the Official List and trading in Britvic Shares on the Main Market 
is expected to take effect by 7:30 a.m. on 20 January 2025. 
Termination of Britvic ADS Programme 
It is also expected that the Britvic ADS Programme will be terminated and the listing of Britvic ADRs on OTCQX will be 
terminated as soon as practicable following the Scheme having become Effective. 
Settlement 
The latest date for the despatch of cheques or electronic payment to Britvic Shareholders, or settlement through CREST 
(as applicable), for the cash consideration and the Special Dividend due under the terms of the Scheme is 30 January 
2025. Please refer to section 17 (Settlement) of Part II (Explanatory Statement) of the Scheme Document for further 
details. 
Other 
All references to times in this announcement are to London time, unless otherwise stated. 
Defined terms used but not defined in this announcement have the meanings set out in the Scheme Document dated 22 July 
2024. 
Enquiries: 
Carlsberg 
                             +45 2219 1221 
Peter Kondrup, Investor Relations 
                             +45 5171 4368 
Kenni Leth, Media Relations 
 
Nomura International plc (Financial Adviser to Carlsberg) 
Adrian Fisk 
Henry Phillips 
                             +44 (0) 20 7102 1000 
Oliver Donaldson 
 
Brunswick Group (PR Adviser to Carlsberg) 
Susan Gilchrist 
Max McGahan                        +44 (0) 20 7404 5959 
Tom Pigott                        carlsberg@brunswickgroup.com 
 
Britvic 
                                                     +44 (0) 7808 
Steve Nightingale, Investor Relations                                  097784 
Kathryn Partridge, Media Relations                                    +44 (0) 7803 
                                                     854229 
 
Morgan Stanley & Co. International plc (Financial Adviser and Corporate Broker to Britvic)        +44 (0) 20 
                                                     7425 8000 
 
Anthony Zammit 
 
Henry Stewart 
 
Paul Baker 
 
Melissa Godoy 
 
Rusheel Somaiya 
 
Europa Partners Limited (Financial Adviser to Britvic)                          +44 (0) 20 
                                                     7451 4542 
Jan Skarbek 
Dominic King 
 
J.P. Morgan Securities plc (which conducts its UK investment banking business as J.P. Morgan Cazenove)  +44 (0) 20 
(Financial Adviser and Corporate Broker to Britvic)                           7742 4000 
Dwayne Lysaght 
Jeannette Smits van Oyen 
Edmund Byers 
 
Headland (PR Adviser to Britvic) 
                                                     +44 (0) 7734 
Stephen Malthouse                                            956 201 
Henry Wallers                                              +44 (0) 7876 
                                                     562 436 
Joanna Clark 
                                                     +44 (0) 7827 
                                                     960 120 

Linklaters LLP is acting as legal adviser to Britvic.

Baker McKenzie LLP is acting as legal adviser to Carlsberg.

Important Notices

Nomura International plc ("Nomura"), which is authorised by the Prudential Regulatory Authority ("PRA") and regulated by the Financial Conduct Authority ("FCA") and the PRA in the United Kingdom, is acting for Carlsberg and for no one else in connection with the distribution of this document and Nomura, its affiliates and its and their respective officers, employees, agents, representatives and/or associates will not regard any other person as their client, nor will they be responsible to anyone other than Carlsberg for providing the protections afforded to clients of Nomura nor for giving advice in connection with the Acquisition or any matter referred to herein.

Morgan Stanley & Co. International plc ("Morgan Stanley") is acting as financial adviser to Britvic and to no one else. Morgan Stanley is authorised by the PRA and regulated in the United Kingdom by the FCA and the PRA. In connection with such matters, Morgan Stanley and its affiliates and its and their respective directors, officers, employees and agents will not regard any other person as its client, nor will Morgan Stanley be responsible to anyone other than Britvic for providing the protections afforded to its clients or for providing advice in connection with the Acquisition or any matter referred to herein.

Europa Partners Limited ("Europa Partners"), which is authorised and regulated by the FCA in the United Kingdom, is acting as joint financial adviser exclusively for Britvic and no one else in connection with the Acquisition and will not be responsible to anyone other than Britvic for providing the protections afforded to its clients or for providing advice in connection with the Acquisition. Neither Europa Partners, nor any of its affiliates, owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Europa Partners in connection with the Acquisition, this announcement, any statement contained herein or otherwise.

J.P. Morgan Securities plc (which conducts its UK investment banking business as J.P. Morgan Cazenove) ("J.P. Morgan Cazenove"), which is authorised in the United Kingdom by the PRA and regulated by the PRA and the FCA, is acting as financial adviser exclusively for Britvic and no one else in connection with the Acquisition and will not regard any other person as its client in relation to the Acquisition and will not be responsible to anyone other than Britvic for providing the protections afforded to clients of J.P. Morgan Cazenove or its affiliates, nor for providing advice in relation to the Acquisition or any other matter or arrangement referred to herein.

Publication on Website

In accordance with Rule 26.1 of the Takeover Code, a copy of this announcement will be made available, subject to certain restrictions relating to persons resident in restricted jurisdictions, on Britvic's website at https:// documentarchive.britvic.com/ and Carlsberg's website at https://www.carlsberggroup.com by no later than 12 noon (London time) on the business day following the date of this announcement. For the avoidance of doubt, the contents of these websites are not incorporated into and do not form part of this announcement.

(MORE TO FOLLOW) Dow Jones Newswires

January 16, 2025 13:08 ET (18:08 GMT)

© 2025 Dow Jones News
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.